Myocyte cell death and ventricular remodeling

Current Opinion in Nephrology and Hypertension

Volumn 6, Issue 2, 1997, Pages 169-176

  Anversa, Piero ^a   Olivetti, Giorgio ^a   Leri, Annarosa ^a   Liu, Yu ^a   Kajstura, Jan ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; CELL DEATH; HEART MUSCLE CELL; HEART VENTRICLE FUNCTION; HEART VENTRICLE WALL; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030917528     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-199703000-00011     Document Type: Review

References (68)

1. Simpson PC, Karuiya K, Karns LR, Long C, Karliner JS: Adrenergic hormones and control of cardiac myocyte growth. Mol Cell Biochem 1991, 104:35-43.
2. Baker KM, Booz GW, Dostal DE: Cardiac actions of angiotensin-II. Role of an intracardiac renin-angiotensin system. Annu Rev Physiol 1992, 54:227-241.
3. Chien KR, Zhu H, Knowlton KU, Miller-Hance W, van Bilsen M, O'Brien TX, Evans S: Transcriptional regulation during cardiac growth and development Annu Rev Physiol 1993, 55:77-95.
4. Mann DL, Urabe Y, Kent RL, Vinciguerra S, Cooper GIV: Cellular versus myocardial basis for the contractile dysfunction of hypertrophied myocardium. Circ Res 1991, 68:402-415.
5. Linzbach AJ: Heart failure from the point of view of quantitative anatomy. Am J Cardiol 2:370-382.
6. Astorri E, Chizzola A, Visioli O, Anversa P, Olivetti G, VitaliMazza L: Right ventricular hypertrophy: a cytometric study on 55 human hearts. J Mol Cell Cardiol 1971, 2:99-110.
7. Astorri E, Bolognesi R, Colla B, Chizzola A, Visioli O: Left ventricular hypertrophy: a cytometric study on 42 human hearts. J Mol Cell Cardiol 1977, 9:763-775.
8. Grajek S, Lesiak M, Pyda M, Zajac M, Paradowski S, Kaczmarek E: Hypertrophy or hyperplasia in cardiac muscle. Post-mortem human morphometric study. Eur Heart J 1993, 14:40-47.
9. Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, Quaini F, Sonnenblick EH, Olivetti G, Anversa P: Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation 1994, 89:151-163.
10. Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, Sonnenblick EH, Olivetti G, Anversa P: The cellular basis of dilated cardiomyopathy in humans. J Mol Cell Cardiol 1995, 27:291-305.
11. Olivetti G, Melissari M, Balbi T, Quaini F, Cigola E, Sonnenblick EH, Anversa P: Myocyte cellular hypertrophy is responsible for ventricular remodelling in the hypertrophied heart of middle aged individuals in the absence of cardiac failure. Cardiovasc Res 1994, 28:1199-1208.
12. Olivetti G, Melissari M, Balbi T, Quaini F, Sonnenblick EH, Anversa P: Myocyte nuclear and possible cellular hyperplasia contribute to ventricular remodeling in the hypertrophic senescent heart in humans. J Am Coll Cardiol 1994, 24:140-149.
13. Olivetti G, Cigola E, Maestri R, Corradi D, Lagrasta C, Gambert SR, Anversa P: Aging, cardiac hypertrophy and ischemic cardiomyopathy do not affect the proportion of mononucleated and multinucleated myocytes in the human heart. J Mol Cell Cardiol 1996, 28:1463-1477.
14. Anversa P, Kajstura J, Cheng W, Reiss K, Cigola E, Olivetti G: Insulin-like growth factor-1 and myocyte growth: the danger of a dogma. Part 1: postnatal myocardial development: normal growth. Cardiovasc Res 1996, 32:219-225.
15. Anversa P, Kajstura J, Cheng W, Reiss K, Cigola E, Olivetti G: Insulin-like growth factor-1 and myocyte growth: the danger of a dogma. Part 2: induced myocardial growth: pathologic hypertrophy. Cardiovasc Res 1996, 32:484-495.
16. Linzbach AJ: Heart hypertrophy and critical heart weight. Klin Wochenschr 1948, 26:459-463.
17. Ferrans V: Cardiac hypertrophy: morphological aspects. In Growth of the Heart and Disease. Edited by Zak R. New York: Raven Press; 1984:187-239.
18. Kajstura J, Zhang X, Reiss K, Szoke E, Li P, Lagrasta C, Cheng W, Darzynkiewicz Z, Olivetti G, Anversa P: Myocyte cellular hyperplasia and myocyte cellular hypertrophy contribute to chronic ventricular remodeling in coronary artery narrowing-induced cardiomyopathy in rats. Circ Res 1994, 74:383-400.
19. Quaini F, Cigola E, Lagrasta C, Saccani G, Quaini E, Rossi C, Olivetti G, Anversa P: End-stage cardiac failure in humans is coupled with the induction of proliferating cell nuclear antigen and nuclear mitotic division in ventricular myocytes. Circ Res 1994, 75:1050-1063.
20. Anversa P, Palackal T, Sonnenblick EH, Olivetti G, Meggs LG, Capasso JM: Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied aging rat heart. Circ Res 1990, 67:871-885.
21. Rumyantsev PP: Replicative behavior of different types of cardiomyocytes in terms of experimental conditions, age and systematic position of animals. In The Development and Regenerative Potential of Cardiac Muscle. Edited by Oberpriller JO, Oberpriller JC, Mauro A. New York: Harwood Academic Publishers; 1991:81-91.
22. Soonpaa MH, Field LJ: Assessment of cardiomyocyte DNA synthesis during hypertrophy in adult mice. Am J Physiol 1994, 266:H1439-H1445.
23. Capasso JM, Palackal T, Olivetti G, Anversa P: Left ventricular failure induced by long-term hypertension in rats. Circ Res 1990, 66:1400-1412.
24. Olivetti G, Giordano G, Corradi D, Melissari M, Lagrasta C, Gambert SR, Anversa P: Gender differences and aging: effects on the human heart. J Am Coll Cardiol 1995, 26:1068-1079.
25. Li P, Zhang X, Capasso JM, Meggs LG, Sonnenblick EH, Anversa P: Myocyte loss and left ventricular failure characterize the long term effects of coronary artery narrowing or renal hypertension in rats. Cardiovasc Res 1993, 27:1066-1075.
26. Anversa P, Olivetti G, Meggs LG, Sonnenblick EH, Capasso JM: Cardiac anatomy and ventricular loading after myocardial infarction. Circulation 1993, 87(suppl):VII22-VII27.
27. Pfeffer MA, Braunwald E: Ventricular remodeling after myocardial infarction-experimental observations and clinical implications. Circulation 1990, 81:1161-1172.
28. Pantely GA, Bulkley BH: Ischemic cardiomyopathy. Prog Cardiovasc Res 1984, 27:95-114.
29. Anversa P, Zhang X, Li P, Capasso JM: Chronic coronary artery constriction leads to moderate myocyte loss and left ventricular dysfunction and failure in rats. J Clin Invest 1992, 89:618-629.
30. Anversa P, Hiler B, Ricci R, Guideri G, Olivetti G: Myocyte cell loss and myocyte hypertrophy in the aging rat heart. J Am Coll Cardiol 1986, 8:1441-1448.
31. Cheng W, Li B, Kajstura J, Li P, Wolin MS, Sonnenblick EH, Hintze TH, • Olivetti G, Anversa P: Stretch-induced programmed myocyte cell death. J Clin Invest 1995, 96:2247-2259. Provides documentation that mechanical forces mimicking pathologic levels of diastolic stress in the myocardium are coupled with the activation of myocyte apoptosis.
32. Reimer KA, Jennings RB: Myocardial ischemia, hypoxia and infarction. In The Heart and Cardiovascular System. Edited by Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE. New York: Raven Press; 1986:1133-1201.
33. Tanaka M, Ito H, Adachi S, Akimoto H, Nishikawa T, Kasajima T, Marumo F, Hiroe M: Hypoxia induces apoptosis with enhanced expression of fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res 1994, 75:426-433.
34. Gottlieb RA, Burleson KO, Kloner RA, Bablor BM, Elgler RL: Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 1994, 94:1621-1628.
35. Kajstura J, Mansukhani M, Cheng W, Reiss K, Krajewski S, Reed JC, Quaini F, Sonnenblick EH, Anversa P: Programmed cell death and the expression of the protooncogene Bcl-2 in myocyte during postnatal maturation of the heart. Exp Cell Res 1995, 219:110-121.
36. Buerke M, Murohara T, Skurk S, Nuss C, Tomaselli K, Lefer AM: •• Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci U S A 1995, 92:8031-8035. This is an important study indicating that insulin-like growth factor-1 has a protective effect on myocyte cell death, apoptotic and necrotic in nature, associated with ischemia reperfusion injury.
37. Gottlieb RA, Gruol DL, Zhu JY, Engler RL: Preconditioning in rabbit •• cardiomyocytes: role of pH, vacuolar proton ATPase, and apoptosis. J Clin Invest 1996, 97:2391-2398. Demonstrates that protein kinase C mediates preconditioning of the myocardium and attenuates apoptosis by activating the vacuolar proton ATPase which reduces intracellular acidification.
38. Itoh G, Tamura J, Suzuki M, Suzuki Y, Ikeda H, Koike M, Nomura M, Jie T, Ito K: DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labelling method and DNA agarose gel electrophoresis. Am J Pathol 1995, 146:1325-1331.
39. Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S, •• Reed JC, Olivetti G, Anversa P: Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 1996, 74:1-22. Provides documentation that apoptotic myocyte cell death is the principal determinant of infarct size in rats.
40. Bardales RH, Hailey LS, Xie SS, Schaefer RF, Hsu SM: In situ •• apoptosis assay for the detection of early acute myocardial infarction. Am J Pathol 1996, 149:821-829. Myocyte apoptosis is the major form of cell death in the infarcted human heart.
41. Olivetti G, Quaini F, Sala R, Lagrasta C, Corradi D, Bonacina E, • Gambert SR, Cigola E, Anversa P: Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J Mol Cell Cardiol 1996, 28:2005-2016. Programmed myocyte cell death affects the region bordering and remote from infarction in humans.
42. Kajstura J, Cheng W, Sarangarajan R, Li P, Li B, Nitahara J, Chapnick S, • Reiss K, Olivetti G, Anversa P: Necrotic and apoptotic myocyte cell death in the aging heart of Fischer 344 rats. Am J Physiol 1996, 271:H1215-H1228. Documents that necrotic and apoptotic myocyte cell death are both involved in the aging process of the heart in rats.
43. Liu Y, Cigola E, Cheng W, Kajstura J, Olivetti G, Hintze TH, Anversa P: Myocyte nuclear mitotic division and programmed myocyte cell death characterize the cardiac myopathy induced by rapid ventricular pacing in dogs. Lab Invest 1995, 73:771-787.
44. Cheng W, Reiss K, Kajstura J, Kowal K, Quaini F, Anversa P: Downregulation of IGF-1 system parallels the attenuation in the proliferative capacity of rat ventricular myocytes during postnatal development. Lab Invest 1995, 72:646-655.
45. Reiss K, Kajstura J, Zhang X, Li P, Szoke E, Olivetti G, Anversa P: Acute myocardial infarction leads to upregulation of the IGF-1 autocrine system, DNA replication and nuclear mitotic division in the remaining viable cardiac myocytes. Exp Cell Res 1994, 213:463-472.
46. Anversa P, Kajstura J, Reiss K, Quaini F, Baldini A, Olivetti G, Sonnenblick EH: Ischemic cardiomyopathy: myocyte cell loss, myocyte cellular hypertrophy and myocyte cellular hyperplasia. In Cardiac Growth and Regeneration, vol 752. Edited by DiNardo P, Claycomb WC. New York: New York Academy of Sciences; 1995:47-64.
47. Reiss K, Cheng W, Giordano A, De Luca A, Li B, Kajstura J, Anversa P: Myocardial infarction is coupled with the activation of cyclins and cyclin-dependent kinases in myocytes. Exp Cell Res 1996, 225:44-54.
48. Cheng W, Kajstura J, Nitahara JA, Li B, Reiss K, Liu Y, Clark WA, •• Krajewski S, Reed JC, Olivetti G, Anversa P: Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp Cell Res 1996, 226:316-327. The structural remodeling of the surviving myocardium after infarction involves myocyte apoptosis and the upregulation of Bax and the downregulation of Bcl-2 in the cells.
49. Iseki S: DNA strand breaks in rat tissues as detected by in situ nick translation. Exp Cell Res 1986, 167:311-326.
50. Wyllie AH, Morris RG, Smith AL, Dunlop D: Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macro-molecular synthesis. J Pathol 1984, 142:67-77.
51. Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S, Reed JC, Olivetti G, Anversa P: Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 1996, 74:86-107.
52. Arends MJ, Morris RG, Wyllie AH: Apoptosis: the role of endonuclease. Am J Pathol 1990, 136:593-608.
53. Darzynkiewicz Z, Juan G, Li X, Gorczyca W, Murakami T, Traganos F: • Cytometry in cell necrobiology. Analysis of apoptosis, accidental cell death and necrosis. Cytometry 1996, in press. This is an excellent review discussing the mechanisms of apoptosis in different cell systems.
54. Benjamin I, Jalil J, Tan L, Cho K, Weber K, Clark W: Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ Res 1989, 67:657-670.
55. Gerschenson LE, Rotello RJ: Apoptosis: a different type of cell death. FASEB J 1992, 6:2450-2455.
56. Zhao MJ, Zhang H, Robinson TF, Factor SM, Sonnenblick EH, Eng C: Profound structural alterations of the extracellular collagen matrix in postischemic dysfunctional ('stunned') but viable myocardium. J Am Coll Cardiol 1987, 10:1322-1334.
57. Sharov VG, Sabbah HN, Shimoyama H, Goussev AV, Lesch M, •• Goldstein S: Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. Am J Pathol 1996, 148:141-149. Provides documentation of apoptotic myocyte cell death in multiple areas of myocardial injury induced by microembolization.
58. Hockenberry DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ: Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993, 75:241-251.
59. Shen W, Xu X, Ochoa M, Zhao G, Wolin MS, Hintze TH: Role of nitric oxide in the regulation of oxygen consumption in conscious dogs. Circ Res 1994, 75:1086-1095.
60. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994, 124:1-6.
61. Kane DJ, Sarafian TA, Auton S, Hahn H, Gralla FB, Valentine JC, Ord T, Bredensen DE: Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 1993, 262:1274-1277.
62. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ: Bcl-2 deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys and hypopigmented hair. Cell 1993, 75:229-240.
63. Oltvai ZN, Korsmeyer SJ: Checkpoints of dueling dimers foil death wishes. Cell 1994, 79:189-192.
64. Miyashita T, Reed J: Tumor suppressor p53 is a direct transcriptional •• activator of the human bax gene. Cell 1995, 80:293-299. This important study demonstrates the regulation of the bax gene by the transcription factor p53.
65. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB: Bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993, 74:597-608.
66. Takayama S, Sato T, Krajewski S, Kochel K, Irie S, Millan JA, Reed JC: Cloning and functional analysis of BAG-1: a novel bcl-2 binding protein with anti-cell death activity. Cell 1995, 80:279-284.
67. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ: Bad, a heterodimeric partner for bcl-xL and bcl-2, displaces bax and promotes cell death. Cell 1995, 80:285-291.
68. Itoh N, Tsujimoto Y, Nagata S: Effect of bcl-2 on Fas antigen-mediated cell death. J Immunol 1993, 151:621-627.